Clinical manifestation | Present study | Ong et al. [18] | Maher et al. [4] |
---|
CNSH | 81.2% (125/154) | Cerebellar 57% Spinal 25% | Cerebellar 59% Spinal 13% |
RCH | 27.9% (43/154) | 73% | 59% |
RCC | 57.8% (89/154) | 35% | 28% |
PCC | 14.9% (23/154) | 20% | 7% |
-
CNSH central nervous system hemangioblastoma, RCH retinal capillary hemangioblastoma, RCC renal cell carcinoma, PCC pheochromocytoma